Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Twice Yearly Treatment for the Control of Lymphatic Filariasis
NCT03036059Phase 4Completed
- Sponsor
- Noguchi Memorial Institute for Medical Research
- Start
- May 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of CHILD-IVITAB, albendazole in lymphatic filariasis (LF), sponsored by Noguchi Memorial Institute for Medical Research. Started May 2017; status: completed.
02
Drugs
CHILD-IVITABalbendazole
03
Conditions
lymphatic filariasis (LF)
Beyond the preview
Go deeper on NCT03036059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03036059.